OmanDocSign in

Curriculum · Gynecology / Women's Health / Infertility / Perinatal Care / Birth Spacing

Breast lump

What it is

A breast mass is assessed by triple assessment: clinical history and examination, imaging, and histopathology or cytology. Benign breast conditions are set out as extra or absence of breast/nipple, normal, aberrations, diseases, and others. Normal is a lumpy breast and changes in relation to the menstrual cycle; involution starts by 30y with microcyst formation, fibrosis and adenosis. Aberrations of breast development are juvenile hypertrophy and fibroadenoma (with phyllodes); aberrations in the early reproductive period are pain (mastalgia) and nodularity; aberrations of involution are cyst, sclerosis and duct ectasia. Diseases are epithelial hyperplasia and mastitis. Others are fat necrosis, intra-ductal papilloma, lipoma, gynecomastia and breast implant rupture. Most benign breast conditions and almost all breast cancers arise within the terminal duct lobular unit.

How it presents

Fibroadenoma is the second most common mass in the breast, common in women under 30 years and in the 15-30 year range. It is mobile, so much so that it is called a breast mouse, firm, non-tender, well-circumscribed and smooth, and on ultrasound well-circumscribed and homogeneous. It develops from a whole lobule, not a single cell, with epithelial and connective tissue elements, and is under the same hormonal control as the rest of the breast. Giant fibroadenoma is more than 5 cm in diameter; juvenile fibroadenoma occurs in adolescent girls. A phyllodes tumor cannot always be clinically differentiated from a fibroadenoma, and some fibroadenomas develop into phyllodes. It comes from periductal stromal cells and has cellular fibrous elements: large, fast growing, palpable, solitary, well-defined, mobile, painless, and it may have axillary lymph nodes. Fibrocystic change gives cyclical pain with lumpiness and simple or complex cysts on ultrasound. On history, the findings that point to cancer rather than a benign lump are nipple discharge or bleeding, nipple inversion, ulceration, dimpling, weight loss, lymphadenopathy and bone pain. Nipple discharge itself is divided by colour and by whether it comes from a single pore or from many. Milky discharge goes with physiological discharge, Galactorrhea and Hyperprolactinemia. Yellowish, with or without greenish, multiple pore discharge in a context of fibrocystic breast disease goes with Mammary duct ectasia and periductal mastitis. Straw-colored single pore discharge stands on its own. Bloody single pore discharge goes with Intra-ductal papilloma and carcinoma. The breast lump differential runs malignant, where invasive ductal carcinoma is the most common, and benign, where the entries are fibroadenoma, breast cyst, which may be painful, and abscess, which gives a painful, hot and swollen breast. Dimpling of the skin does not necessarily imply invasion of cancer into the underlying musculature: an intra-mammary tumour can pull on a ligament of Astley Cooper, causing dimpling of the skin, and raising the hands above the head accentuates it. In women between the ages of 20 and 50 only about 10% of palpable masses are malignant, and fibroadenomas are most commonly found in women aged 15-35, where mobile, firm, smooth and rubbery is what distinguishes the mass from a cyst, a carcinoma, a lymphoma and a phyllodes tumour.

How it is diagnosed

Imaging follows age. Under 35 years old, ultrasound; over 35 years old, ultrasound plus mammogram. In young ages the breast is dense with more glandular tissue while in older ages fat replaces the glands, which is why mammogram is not very sensitive in young ages. Mammogram is contraindicated in lactating and pregnant women. MRI is for the post-treated breast, for concern about multifocality or multicenter disease in a young patient, or in BRCA1 and 2. Tissue completes the triple assessment. In a 25-year-old woman with a mobile, firm, rubbery lump after ultrasound, the next step is core-needle biopsy; FNAC is less accurate. Above 2 cm a true cut biopsy gives more information to differentiate fibroadenoma from phyllodes, hence important for management, and for phyllodes true cut is better because FNAC has difficulty of obtaining adequate numbers of stromal cells for cytogenic analysis. Imaging is reported by BIRADS: 1 negative and 2 benign, routine screening; 3 probably benign, less than 2 percent, follow-up imaging at six and 12 months; 4 suspicious, 12 to 25 percent, fine-needle aspiration or percutaneous or surgical biopsy; 5 highly suggestive, greater than 95 percent, spiculated mass; 6 known malignancy. A second table scores the same BIRADS categories differently: 3 probably benign is a finding with a high probability of being benign, greater than 98 percent, with six-month short interval follow-up; 4 suspicious abnormality is not characteristic of breast cancer but has a reasonable probability of being malignant, 3 to 94 percent, and biopsy should be considered; and 5 highly suspicious of malignancy has a high probability of being malignant, 95 percent or more. A simple fibroadenoma is BIRAD 2, and BIRADS 2 needs no further test. The age at which the imaging changes is asked on its own: mammogram is used if the patient is over 35 years and ultrasound if the patient is under 35 years, and the reason given is the high density of the breast in the young. Every patient who comes with any breast condition moves through the triple assessment, and the history must never leave out the risk factors for malignancy: age, age at menarche, age at menopause, age at first child, breastfeeding or not, use of OCP, and family history. The radiologist then describes the lesion and gives it a BIRADS category from 0 to 6, and the higher the category the more likely the lesion is suspicious and the more evaluation it requires. The examination itself has an order. On inspection the breasts and the axillae are compared, with the hands resting by the side, then pushing down on the bed, then pushing in on the hips, then slowly raising straight arms above the head, which is the good test to show dimpling. What is looked for is an obvious lump, skin change, inversion, discharge with its colour and any blood-staining, Paget's disease of the nipple, and scars from previous surgery such as mastectomy, lumpectomy or axillary node clearance. For palpation the patient lies flat with the hands behind the head; each breast is assessed in turn, the normal one first, with the pads of 3 fingers moving systematically, as on a clock face, and a lump found is assessed as any other lump would be, then the axillary tail, the axillary lymph nodes and the lymph nodes of the head and neck. The examination is concluded by asking to examine the other breast and by completing triple assessment of any lump identified, which is examination, imaging with mammography or ultrasound, and fine needle aspiration.

The whole of it is put in three lines called the golden rule of triple assessment: clinical exam; imaging, with US <35y, mammogram >40, and MRI for high-risk or dense breasts; and core biopsy, preferred over FNAC.

Two things in that are worth holding against what is written above. The age at which the mammogram enters is given as over 40 here and as over 35 elsewhere, and both stand as written; and the choice between the two needles is the same in both, core biopsy over FNAC.

Set down as the golden rule, triple assessment is three things and no more: clinical exam; imaging, with US under 35y, mammogram over 40, and MRI for high-risk or dense breasts; and core biopsy, preferred over FNAC. So the third leg of the triple assessment is named as core biopsy, not as fine-needle aspiration, and the preference is written into the rule itself rather than left to the size of the lesion.

The age at which the mammogram starts is not written the same way in both places. One gives ultrasound under 35 years old and ultrasound plus mammogram over 35 years old; the other gives US under 35y and mammogram over 40. Both are set down as they are written, and the band between 35 and 40 is where they part. What they do agree on is the reason: the breast of the young woman is dense with more glandular tissue, so the mammogram is not very sensitive there, and MRI is the one added for the dense or high-risk breast.